Hoa Tran

Combined treatment with APCC (FEIBA^®) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A – a two‐centre experience

Mats Holmström, Hoa Tran, Pål André Holme · Haemophilia · 2012 · 65 citations

Medicine, Hematology, Pharmacology +17

Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

Arnon P. Kater, Mark‐David Levin, Julie Dubois et al. · The Lancet Oncology · 2022 · 58 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

Monitoring bypassing agent therapy – a prospective crossover study comparing thromboelastometry and thrombin generation assay

Hoa Tran, Benny Sørensen, Stine Bjørnsen et al. · Haemophilia · 2014 · 41 citations

Medicine, Hematology, Pharmacology +17

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Eun Young Kang, Dane Cheasley, Cécile Le Page et al. · Modern Pathology · 2020 · 41 citations · Full text

Medicine, Gynecology, Oncology +17

Tranexamic acid as adjunct therapy to bypassing agents in haemophilia<scp>A</scp>patients with inhibitors

Hoa Tran, Benny Sørensen, Catherine Rea et al. · Haemophilia · 2013 · 40 citations

Medicine, Hematology, Pharmacology +17